Betta Pharmaceuticals Co., Ltd.

Informe acción SZSE:300558

Capitalización de mercado: CN¥20.7b

Salud financiera de hoja de balance de Betta Pharmaceuticals

Salud financiera controles de criterios 3/6

Betta Pharmaceuticals tiene un patrimonio de accionistas total de CN¥5.7B y una deuda total de CN¥2.3B, lo que sitúa su ratio deuda-patrimonio en 40.6%. Sus activos y pasivos totales son CN¥9.4B y CN¥3.6B respectivamente. El BAIT de Betta Pharmaceuticals es de CN¥406.6M, por lo que su ratio de cobertura de intereses es de 11.2. Tiene efectivo e inversiones a corto plazo que ascienden a CN¥816.4M.

Información clave

40.6%

Ratio deuda-patrimonio

CN¥2.32b

Deuda

Ratio de cobertura de intereses11.2x
EfectivoCN¥816.38m
PatrimonioCN¥5.73b
Total pasivoCN¥3.63b
Activos totalesCN¥9.36b

Actualizaciones recientes sobre salud financiera

These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well

Jul 05
These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well

Recent updates

We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings

Nov 04
We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings

Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Still On The Mark Following 29% Share Price Bounce

Sep 30
Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Still On The Mark Following 29% Share Price Bounce

Results: Betta Pharmaceuticals Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 07
Results: Betta Pharmaceuticals Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Unpleasant Surprises Could Be In Store For Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) Shares

Jul 30
Unpleasant Surprises Could Be In Store For Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) Shares

These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well

Jul 05
These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well

Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem

Apr 26
Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem

Earnings Miss: Betta Pharmaceuticals Co., Ltd. Missed EPS By 6.1% And Analysts Are Revising Their Forecasts

Apr 23
Earnings Miss: Betta Pharmaceuticals Co., Ltd. Missed EPS By 6.1% And Analysts Are Revising Their Forecasts

What Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Not Telling You

Apr 16
What Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Not Telling You

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (CN¥1.5B) de 300558 no cubren sus pasivos a corto plazo (CN¥1.8B).

Pasivo a largo plazo: Los activos a corto plazo (CN¥1.5B) de 300558 no cubren sus pasivos a largo plazo (CN¥1.9B).

Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (26.3%) de 300558 se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de 300558 ha crecido de 26.5% a 40.6% en los últimos 5 años.

Cobertura de la deuda: La deuda de 300558 está bien cubierta por el flujo de caja operativo (51%).

Cobertura de intereses: Los pagos de intereses de la deuda de 300558 están bien cubiertos por el BAIT (11.2x cobertura).

Hoja de balance

Descubre empresas con salud financiera

7D

1Y

7D

1Y

7D

1Y